Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Jan;57(1):43–47. doi: 10.1038/bjc.1988.6

Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.

P Terrier 1, Z M Sheng 1, M Schlumberger 1, M Tubiana 1, B Caillou 1, J P Travagli 1, P Fragu 1, C Parmentier 1, G Riou 1
PMCID: PMC2246694  PMID: 3348948

Abstract

Tumour specimens from 23 patients with thyroid carcinoma, 22 patients with thyroid adenoma, 3 with Graves' disease, and tissues from 8 normal thyroid glands were analyzed by Southern blot hybridization for the physical state of c-myc and c-fos proto-oncogenes. In 4 patients, both the primary tumour and lymph node metastases were analyzed. No amplification or rearrangement of the two proto-oncogenes was detected. Total RNAs were also analyzed. Elevated levels of the 2.4 kb c-myc RNA and of the 2.2 kb c-fos RNA were found in 13/23 (57%) and 14/23 (61%) of the cancer patients, respectively. High levels of c-myc transcripts were more frequently found in thyroid carcinomas with unfavourable prognosis. Concomitant elevated levels of both c-myc and c-fos RNAs were found in 8 cancers. High levels of c-myc RNA were also found in 1 out of 22 specimens of adenoma, in 1 specimen of Graves' disease and in 2 normal thyroid glands. High levels of c-fos RNA were found in 20 of the 22 adenoma samples and in 2 out of 8 normal thyroid tissues. These data indicate that the overexpression of c-myc and c-fos genes is independent of an alteration of the loci. The high levels of c-fos found in adenoma may be associated with the differentiation state of these tumours.

Full text

PDF
43

Images in this article

45Figure 1
on p.45
45Figure 2
on p.45
45Figure 3
on p.45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alitalo K., Schwab M. Oncogene amplification in tumor cells. Adv Cancer Res. 1986;47:235–281. doi: 10.1016/s0065-230x(08)60201-8. [DOI] [PubMed] [Google Scholar]
  2. Alonso S., Minty A., Bourlet Y., Buckingham M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol. 1986;23(1):11–22. doi: 10.1007/BF02100994. [DOI] [PubMed] [Google Scholar]
  3. Byar D. P., Green S. B., Dor P., Williams E. D., Colon J., van Gilse H. A., Mayer M., Sylvester R. J., van Glabbeke M. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979 Aug;15(8):1033–1041. doi: 10.1016/0014-2964(79)90291-3. [DOI] [PubMed] [Google Scholar]
  4. Colletta G., Cirafici A. M., Vecchio G. Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture. Science. 1986 Jul 25;233(4762):458–460. doi: 10.1126/science.3726540. [DOI] [PubMed] [Google Scholar]
  5. Cory S. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res. 1986;47:189–234. doi: 10.1016/s0065-230x(08)60200-6. [DOI] [PubMed] [Google Scholar]
  6. Curran T., Peters G., Van Beveren C., Teich N. M., Verma I. M. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol. 1982 Nov;44(2):674–682. doi: 10.1128/jvi.44.2.674-682.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dani C., Blanchard J. M., Piechaczyk M., El Sabouty S., Marty L., Jeanteur P. Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci U S A. 1984 Nov;81(22):7046–7050. doi: 10.1073/pnas.81.22.7046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dere W. H., Hirayu H., Rapoport B. TSH and cAMP enhance expression of the myc proto-oncogene in cultured thyroid cells. Endocrinology. 1985 Nov;117(5):2249–2251. doi: 10.1210/endo-117-5-2249. [DOI] [PubMed] [Google Scholar]
  9. Dere W. H., Hirayu H., Rapoport B. Thyrotropin and cyclic AMP regulation of ras proto-oncogene expression in cultured thyroid cells. FEBS Lett. 1986 Feb 17;196(2):305–308. doi: 10.1016/0014-5793(86)80268-x. [DOI] [PubMed] [Google Scholar]
  10. Erisman M. D., Rothberg P. G., Diehl R. E., Morse C. C., Spandorfer J. M., Astrin S. M. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol. 1985 Aug;5(8):1969–1976. doi: 10.1128/mcb.5.8.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fritsch E. F., Lawn R. M., Maniatis T. Molecular cloning and characterization of the human beta-like globin gene cluster. Cell. 1980 Apr;19(4):959–972. doi: 10.1016/0092-8674(80)90087-2. [DOI] [PubMed] [Google Scholar]
  12. Gonda T. J., Metcalf D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature. 1984 Jul 19;310(5974):249–251. doi: 10.1038/310249a0. [DOI] [PubMed] [Google Scholar]
  13. Greenberg M. E., Hermanowski A. L., Ziff E. B. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol Cell Biol. 1986 Apr;6(4):1050–1057. doi: 10.1128/mcb.6.4.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Guérin M., Lacombe M. J., Riou G. Analyse de l'expression de l'oncogène c-myc dans les adénocarcinomes mammaires humains. C R Acad Sci III. 1985;301(20):833–838. [PubMed] [Google Scholar]
  15. Hendy-Ibbs P., Cox H., Evan G. I., Watson J. V. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Br J Cancer. 1987 Mar;55(3):275–282. doi: 10.1038/bjc.1987.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lehn P., Sigaux F., Grausz D., Loiseau P., Castaigne S., Degos L., Flandrin G., Dautry F. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia. Blood. 1986 Oct;68(4):967–970. [PubMed] [Google Scholar]
  17. Little C. D., Nau M. M., Carney D. N., Gazdar A. F., Minna J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature. 1983 Nov 10;306(5939):194–196. doi: 10.1038/306194a0. [DOI] [PubMed] [Google Scholar]
  18. Mavilio F., Sposi N. M., Petrini M., Bottero L., Marinucci M., De Rossi G., Amadori S., Mandelli F., Peschle C. Expression of cellular oncogenes in primary cells from human acute leukemias. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4394–4398. doi: 10.1073/pnas.83.12.4394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Modjtahedi N., Lavialle C., Poupon M. F., Landin R. M., Cassingena R., Monier R., Brison O. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line. Cancer Res. 1985 Sep;45(9):4372–4379. [PubMed] [Google Scholar]
  20. Müller R. Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. Biochim Biophys Acta. 1986;823(3):207–225. doi: 10.1016/0304-419x(86)90003-x. [DOI] [PubMed] [Google Scholar]
  21. Müller R., Müller D., Verrier B., Bravo R., Herbst H. Evidence that expression of c-fos protein in amnion cells is regulated by external signals. EMBO J. 1986 Feb;5(2):311–316. doi: 10.1002/j.1460-2075.1986.tb04214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pfeifer-Ohlsson S., Rydnert J., Goustin A. S., Larsson E., Betsholtz C., Ohlsson R. Cell-type-specific pattern of myc protooncogene expression in developing human embryos. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5050–5054. doi: 10.1073/pnas.82.15.5050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rabbitts P. H., Forster A., Stinson M. A., Rabbitts T. H. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability. EMBO J. 1985 Dec 30;4(13B):3727–3733. doi: 10.1002/j.1460-2075.1985.tb04141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Riou G., Barrois M., Lê M. G., George M., Le Doussal V., Haie C. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet. 1987 Apr 4;1(8536):761–763. doi: 10.1016/s0140-6736(87)92795-4. [DOI] [PubMed] [Google Scholar]
  25. Riou G., Barrois M., Tordjman I., Dutronquay V., Orth G. Présence de génomes de papillomavirus et amplification des oncogènes c-myc et c-Ha-ras dans des cancers envahissants du col de l'utérus. C R Acad Sci III. 1984;299(14):575–580. [PubMed] [Google Scholar]
  26. Rothberg P. G., Erisman M. D., Diehl R. E., Rovigatti U. G., Astrin S. M. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol Cell Biol. 1984 Jun;4(6):1096–1103. doi: 10.1128/mcb.4.6.1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schlumberger M., Charbord P., Fragu P., Lumbroso J., Parmentier C., Tubiana M. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab. 1980 Sep;51(3):513–519. doi: 10.1210/jcem-51-3-513. [DOI] [PubMed] [Google Scholar]
  28. Schlumberger M., Tubiana M., De Vathaire F., Hill C., Gardet P., Travagli J. P., Fragu P., Lumbroso J., Caillou B., Parmentier C. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986 Oct;63(4):960–967. doi: 10.1210/jcem-63-4-960. [DOI] [PubMed] [Google Scholar]
  29. Tramontano D., Chin W. W., Moses A. C., Ingbar S. H. Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells. J Biol Chem. 1986 Mar 25;261(9):3919–3922. [PubMed] [Google Scholar]
  30. Tubiana M., Schlumberger M., Rougier P., Laplanche A., Benhamou E., Gardet P., Caillou B., Travagli J. P., Parmentier C. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985 Feb 15;55(4):794–804. doi: 10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  31. Yamashita S., Ong J., Fagin J. A., Melmed S. Expression of the myc cellular proto-oncogene in human thyroid tissue. J Clin Endocrinol Metab. 1986 Nov;63(5):1170–1173. doi: 10.1210/jcem-63-5-1170. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES